ADAMTS5 and rheumatoid arthritis: In 2005, two independent landmark studies demonstrated that ADAMTS5 catalytic inactivation protected mice from experimentally induced OA and rheumatoid arthritis (RA) [33,34] but that ADAMTS4-deficient or catalytically inactivated mice did not show this same protection.